A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With Ischemic Stroke
Clinical trial NCT01297413 · COMPLETED
Trial details
- NCT number
- NCT01297413
- Sponsor
- Stemedica Cell Technologies, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-01
- Primary completion
- 2017-09-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.